A summary of current sequencing methods for patients with Meniere’s disease from the review. Image: Genes & Diseases. The endolymphatic sac may represent a central site where multiple disease-triggering factors converge in Ménière’s disease, a new review suggests....
Continue reading at Hearing Practitioner Australia
✦ The floor
Discussion
Signed responses from readers of the wire.
No immediate change to clinical practice is warranted; this is a pathophysiology review that lays theoretical groundwork for future targeted therapies rather than providing actionable treatment guidance today.
Identifying the endolymphatic sac as a convergence hub for Ménière's disease triggers could redirect research and eventually drug development toward more precise, mechanism-based interventions.
- 01Review identifies the endolymphatic sac as a central convergence point for multiple Ménière's disease triggers.
- 02Published in Genes & Diseases, linking genetic, metabolomic, proteomic, and transcriptomic factors.
- 03Multi-omics approach (genomics, proteomics, metabolomics, transcriptomics) used to frame disease mechanisms.
- 04Findings point toward targeted, mechanism-based treatment strategies rather than symptomatic management.
- 05No new clinical trial data presented; this is a synthesised theoretical framework.
The endolymphatic sac acts as a convergence point for multiple disease-triggering factors in Ménière's disease.
studypartially supportedTargeting the endolymphatic sac may lead to more effective treatments for Ménière's disease.
opinionunclear- Journal
- Genes & Diseases
- Publication type
- review
- Evidence level
- 5
- Population
- Not applicable — review of Ménière's disease pathophysiology literature
- Intervention
- Narrative/systematic review of endolymphatic sac biology and multi-omics disease mechanisms
Primary outcomes
Identification of the endolymphatic sac as a convergence point for Ménière's disease triggers; Proposal of targeted treatment approaches based on disease mechanisms